Gary Hoffman, head of the IP group at Dickstein Shapiro, the 400-lawyer general practice firm based in Washington, D.C, was already in a hiring mode when he headed to Texas this winter for an infringement trial against Boston Scientific Corp. on behalf of Dr. Bruce Saffran, a New Jersey radiologist who had patented drug-coated heart stents. But the gigantic win for Saffran?$431 million?sure provided Hoffman with a timely recruiting tool. Because Dickstein took the case partially on contingency, if the verdict stands up, the firm could earn tens of millions of dollars in fees, possibly more than $100 million.
The win “obviously has gotten us additional attention,” says Hoffman, who served as cocounsel for Saffran on the trial in U.S. district court in Marshall, Texas. “It absolutely enhances our reputation and gets our name out there.” Since the start of the year, Dickstein’s IP group has added seven lateral partners from Morgan & Finnegan, Akin Gump, and Arnold & Porter.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
